Kerman University of Medical Sciences

Document Type: Original Article

Authors

1 Taleghani Hospital Research Development Committee, Behavioral Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2 Department of Psychiatry, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Abstract

Background: Opioid use disorder is a major concern to public health, and opioid maintenance treatment on
methadone or buprenorphine is a widely used approach. On the other hand, in recent years, there has been
more regards for the use of opium tincture for detoxification and maintenance treatment of opioid
dependence in certain parts of the world. The purpose of our research was to compare sexual impairments of
methadone maintenance treatment (MMT), buprenorphine maintenance treatment (BMT), and opium
tincture maintenance treatment (OMT) in patients.
Methods: The study sample consisted of opium-addicted men candidates for maintenance treatment in an
addiction quitting clinic in Tehran, Iran, from November 2017 to February 2018. Participants (n = 84) were
randomly assigned to three groups (of the equal number), receiving either methadone tablet, buprenorphine
sublingual tablet, and opium tincture. The average score for sexual function was evaluated using the Arizona
Sexual Experiences Scale (ASEX) at the beginning and after 3 months after treatment.
Findings: Although there was no significant different in ASEX scores between the groups at the beginning
and end of the study (P > 0.05), but the difference was significant in each group in comparing by themselves.
Conclusion: These results showed that sexual dysfunction became better after opioid substitution therapies,
and no differences were observed on sexual dysfunction between the three groups


Keywords

United Nations Office on Drugs and Crime
(UNODC). World Drug Report 2016 [Online]. [cited
2016 May]; Available from: URL:
https://www.unodc.org/doc/wdr2016/WORLD_DR
UG_REPORT_2016_web.pdf
2. Chen W, Li X, Li X, Ling L, Xia Y, Chen J, et al.
Erectile dysfunction among male heroin addicts
receiving methadone maintenance treatment in
Guangdong, China. J Addict Med 2012; 6(3): 212-8.
3. Hanbury R, Cohen M, Stimmel B. Adequacy of
sexual performance in men maintained on
methadone. Am J Drug Alcohol Abuse 1977; 4(1):
13-20.
4. Xia Y, Zhang D, Li X, Chen W, He Q, Jahn HJ, et al.
Sexual dysfunction during methadone maintenance
treatment and its influence on patient's life and
treatment: A qualitative study in South China.
Psychol Health Med 2013; 18(3): 321-9.
5. Ramdurg S, Ambekar A, Lal R. Sexual dysfunction
among male patients receiving buprenorphine and
naltrexone maintenance therapy for opioid
dependence. J Sex Med 2012; 9(12): 3198-204.
6. Trajanovska AS, Vujovic V, Ignjatova L, JanicevicIvanovska D, Cibisev A. Sexual dysfunction as a
side effect of hyperprolactinemia in methadone
maintenance therapy. Med Arch 2013; 67(1): 48-50.
7. Sarkhel S. Kaplan and Sadock's Synopsis of
Psychiatry: Behavioral Sciences/Clinical Psychiatry,
10th edition. Indian J Psychiatry 2009; 51(4): 331.
8. Maremmani I. The principles and practice of
methadone treatment. Pisa, Italy: Pacini Editore
Medicina; 2012.
9. Brotto LA, Chik HM, Ryder AG, Gorzalka BB, Seal
BN. Acculturation and sexual function in asian
women. Arch Sex Behav 2005; 34(6): 613-26.
10. Walsh SL, Eissenberg T. The clinical pharmacology
of buprenorphine: extrapolating from the laboratory
to the clinic. Drug Alcohol Depend 2003; 70(2
Suppl): S13-S27.
11. Johnson RE, Chutuape MA, Strain EC, Walsh SL,
Stitzer ML, Bigelow GE. A comparison of
levomethadyl acetate, buprenorphine, and
methadone for opioid dependence. N Engl J Med
2000; 343(18): 1290-7.
12. Heidari Z, Mahmoudzadeh-Sagheb H, Kohan F. A
quantitative and qualitative study of rat testis
following administration of methadone and
buprenorphine. Int J High Risk Behav Addict 2012;
1(1): 14-7.
13. Quaglio G, Lugoboni F, Pattaro C, Melara B,
Mezzelani P, Des Jarlais DC. Erectile dysfunction in
male heroin users, receiving methadone and
buprenorphine maintenance treatment. Drug Alcohol
Depend 2008; 94(1-3): 12-8.
14. Yee A, Danaee M, Loh HS, Sulaiman AH, Ng CG.
Sexual dysfunction in heroin dependents: a
comparison between methadone and buprenorphine
maintenance treatment. PLoS One 2016; 11(1):
e0147852.
15. Hallinan R, Byrne A, Agho K, McMahon CG, Tynan
P, Attia J. Hypogonadism in men receiving
methadone and buprenorphine maintenance
treatment. Int J Androl 2009; 32(2): 131-9.
16. Maguet O, Majeed M. Implementing harm reduction
for heroin users in Afghanistan, the worldwide opium
supplier. Int J Drug Policy 2010; 21(2): 119-21.
17. Alam Mehrjerdi Z, Zarghami M. Maintenance
therapy with opium tincture for injecting drug users;
implications for prevention from viral infections.
Hepat Mon 2013; 13(4): e8334.
18. Jittiwutikarn J, Ali R, White JM, Bochner F,
Somogyi AA, Foster DJ. Comparison of tincture of
opium and methadone to control opioid withdrawal
in a Thai treatment centre. Br J Clin Pharmacol
2004; 58(5): 536-41.
19. Momtazi S, Noroozi A, Rawson RA. An Overview
of iran drug treatment and harm reduction programs.
In: el-Guebaly N, Carra G, Galanter M, editors.
Textbook of addiction treatment: International
perspectives. Milano, Italy: Springer Milan; 2015. p.
543-54.
20. Brown R, Balousek S, Mundt M, Fleming M.
Methadone maintenance and male sexual
dysfunction. J Addict Dis 2005; 24(2): 91-106.
21. Pezeshki MZ, Bayrami R. Reliability and construct
validity of Arizona Sexual Experiences Scale
(ASEX) among pregnant women referred to Tabriz
urban health centers, 2004. Proceedings of 2nd
National Congress on Family and Sexual Problems;
2005 Oct 25-26; Tehran, Iran.
22. Hassanipour Azgomi S, Arab Zozani M, Maghsoudi
A, Mokhtari AM, Ghadiri Rad R. Comparing sexual
dysfunction in maintenance therapy with Methadone
and Buprenorphine in married male. International
Journal of Epidemiologic Research 2016; 3(3): 232-8.
23. Tafreshian S, Javadi M, Fakhraei F, Fatemi SS.
Sexual dysfunction in male patients receiving
methadone and buprenorphine maintenance
treatment in Iran. Heroin Addiction and Related
Clinical Problems 2014; 16(3): 49-54.
24. Yee A, Loh HS, Hisham Hashim HM, Ng CG. The
prevalence of sexual dysfunction among male
patients on methadone and buprenorphine
treatments: A meta-analysis study. J Sex Med 2014;
11(1): 22-32.
25. Galea S, Vlahov D. Social determinants and the
Opioid Substitution Therapies on Sexual Function Kheradmand et al.
Addict Health, Spring 2019; Vol 11, No 2 127
http://ahj.kmu.ac.ir, 04 April
health of drug users: Socioeconomic status,
homelessness, and incarceration. Public Health Rep
2002; 117(Suppl 1): S135-S145.
26. Bawor M, Bami H, Dennis BB, Plater C, Worster A,
Varenbut M, et al. Testosterone suppression in
opioid users: A systematic review and meta-analysis.
Drug Alcohol Depend 2015; 149: 1-9.
27. Gladue BA, Clemens LG. Flutamide inhibits
testosterone-induced masculine sexual behavior in
male and female rats. Endocrinology 1980; 106(6):
1917-22.
28. Nimroozi R, Mastropietro MJ, Omidia H. Opioid
abuse and deterrence: Buprenorphine products. J
Develop Drugs 2014; 3: 1.
29. Cicero TJ, Wilcox CE, Bell RD, Meyer ER. Acute
reductions in serum testosterone levels by narcotics
in the male rat: stereospecificity, blockade by
naloxone and tolerance. J Pharmacol Exp Ther 1976;
198(2): 340-6.
30. Yilmaz B, Konar V, Kutlu S, Sandal S, Canpolat S,
Gezen MR, et al. Influence of chronic morphine
exposure on serum LH, FSH, testosterone levels, and
body and testicular weights in the developing male
rat. Arch Androl 1999; 43(3): 189-96.
31. Cicero TJ, Adams ML, Giordano A, Miller BT,
O'Connor L, Nock B. Influence of morphine exposure
during adolescence on the sexual maturation of male
rats and the development of their offspring. J
Pharmacol Exp Ther 1991; 256(3): 1086-93.
32. Gabriel SM, Clark JT, Kalra PS, Kalra SP, Simpkins
JW. Chronic morphine and testosterone treatment:
effects on norepinephrine and serotonin metabolism
and gonadotropin secretion in male rats. Brain Res
1988; 447(1): 200-3.
33. Ahmadnia H, Akhavan RA, Hoseyni M, Sharifi N,
Khajedalooee M, Akhavan RA. Short-period
influence of chronic morphine exposure on serum
levels of sexual hormones and spermatogenesis in
rats. Nephrourol Mon 2016; 8(4): e38052.
34. Ajo R, Segura A, Inda MD, Margarit C, Ballester P,
Martinez E, et al. Erectile dysfunction in patients
with chronic pain treated with opioids. Med Clin
(Barc) 2017; 149(2): 49-54.
35. Ajo R, Segura A, Inda MM, Planelles B, Martinez L,
Ferrandez G, et al. Opioids increase sexual
dysfunction in patients with non-cancer pain. J Sex
Med 2016; 13(9): 1377-86.
36. Levine SB. The nature of sexual desire: A clinician's
perspective. Arch Sex Behav 2003; 32(3): 279-85.
37. Rowland D, McMahon CG, Abdo C, Chen J,
Jannini E, Waldinger MD, et al. Disorders of
orgasm and ejaculation in men. J Sex Med 2010;
7(4 Pt 2): 1668-86.
38. Chekuri V, Gerber D, Brodie A, Krishnadas R.
Premature ejaculation and other sexual dysfunctions
in opiate dependent men receiving methadone
substitution treatment. Addict Behav 2012; 37(1):
124-6.
39. Deglon JJ, Martin JL, Imer RL. Methadone patients'
sexual dysfunctions: Clinical and treatment issues.
Heroin Add & Rel Clin Probl 2004; 6(3): 17-26.
40. Shinderman MS, Maxwell S. Sexual dysfunction
associated with methadone maintenance: Treatment
with bromocryptine. Heroin Add & Rel Clin Probl
2000; 2(1): 9-14.
41. Kandeel FR, Koussa VK, Swerdloff RS. Male sexual
function and its disorders: physiology,
pathophysiology, clinical investigation, and
treatment. Endocr Rev 2001; 22(3): 342-88.
42. Feldman HA, Goldstein I, Hatzichristou DG, Krane
RJ, McKinlay JB. Impotence and its medical and
psychosocial correlates: results of the Massachusetts
Male Aging Study. J Urol 1994; 151(1): 54-61.
43. Rosen MP, Greenfield AJ, Walker TG, Grant P,
Dubrow J, Bettmann MA, et al. Cigarette smoking:
An independent risk factor for atherosclerosis in the
hypogastric-cavernous arterial bed of men with
arteriogenic impotence. J Urol 1991; 145(4):
759-63.
44. Araujo AB, Johannes CB, Feldman HA, Derby CA,
McKinlay JB. Relation between psychosocial risk
factors and incident erectile dysfunction: prospective
results from the Massachusetts Male Aging Study.
Am J Epidemiol 2000; 152(6): 533-41.
45. Sbrocco T, Weisberg RB, Barlow DH, Carter MM.
The conceptual relationship between panic disorder
and male erectile dysfunction. J Sex Marital Ther
1997; 23(3): 212-20.